Literature DB >> 22052454

Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners.

Giuseppe Lippi1, Federico Schena, Gian Luca Salvagno, Cantor Tarperi, Rosalia Aloe, Gian Cesare Guidi.   

Abstract

Cardiac troponins are a mainstay in the diagnostic approach of patients with suspected acute coronary syndrome. Along with other causes of cardiac injury, strenuous aerobic exercise is an important source of troponin leakage from myocardium. Due to recent immunoassays development, there is no information on variation of highly-sensitive (HS) troponin I (TnI) in ultra-marathon runners. We studied 15 healthy trained Caucasian athletes before and immediately after completion of a 60 km, ultra-marathon. TnI was measured with both the conventional AccuTnI and the novel HS-AccuTnI immunoassays. At the end of the ultra-marathon the concentration of HS-AccuTnI significantly increased from the baseline value (19.2 ± 4.2 vs. 5.2 ± 0.8 ng/l; P = 0.001). The number of athletes displaying HS-AccuTnI values exceeding the 99th percentile of the reference limit was 2 (13%) pre-exercise, increasing significantly to 12 (80%; P < 0.001) post-exercise. Measurable value of AccuTnI were found in 1 (7%) and 12 (80%; P < 0.001) athletes pre- and post exercise, respectively. All AccuTnI values were below the 99th percentile reference limit pre-exercise, whereas this cut-off was overcome in 20% of athletes, post-exercise. These results suggest that the myocardium release of TnI during strenuous aerobic exercise mirrors that of troponin T. Moreover, the improved sensitivity of the HS-AccuTnI over the conventional assay makes it more suited for detecting even minor elevations of TnI in blood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22052454     DOI: 10.1007/s11239-011-0651-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

Review 1.  Cardiac troponins and physical exercise. It's time to make a point.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Giuseppe Banfi; Mario Plebani
Journal:  Biochem Med (Zagreb)       Date:  2011       Impact factor: 2.313

2.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White
Journal:  J Am Coll Cardiol       Date:  2007-11-27       Impact factor: 24.094

3.  High-sensitive troponin testing and the "runner's syndrome".

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  J Emerg Med       Date:  2009-08-13       Impact factor: 1.484

4.  Sensitive cardiac troponin T assay.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Mario Plebani
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

5.  Cardiac troponin T release and inflammation demonstrated in marathon runners.

Authors:  Silvia Gilka Munzoz Saravia; Fabian Knebel; Sabrina Schroeckh; Reinhard Ziebig; Andreas Lun; Andreas Weimann; Annekathrin Haberland; Adrian C Borges; Ingolf Schimke
Journal:  Clin Lab       Date:  2010       Impact factor: 1.138

6.  72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon.

Authors:  Johannes Scherr; Siegmund Braun; Tibor Schuster; Charlotte Hartmann; Stefan Moehlenkamp; Bernd Wolfarth; Axel Pressler; Martin Halle
Journal:  Med Sci Sports Exerc       Date:  2011-10       Impact factor: 5.411

7.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

8.  Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications.

Authors:  Giuseppe Lippi; Giovanni Targher; Massimo Franchini; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

Review 9.  Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?

Authors:  Alberto Giannoni; Stefania Giovannini; Aldo Clerico
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

10.  Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury.

Authors:  Peter A Kavsak; Andrew R MacRae; Marie-Jeanne Yerna; Allan S Jaffe
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

View more
  6 in total

Review 1.  Pre-analytic variability in cardiovascular biomarker testing.

Authors:  Roberto Cemin; Massimo Daves
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 2.  Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches?

Authors:  F Sanchis-Gomar; H Pareja-Galeano; C Perez-Quilis; A Santos-Lozano; C Fiuza-Luces; N Garatachea; G Lippi; A Lucia
Journal:  Cell Stress Chaperones       Date:  2014-09-03       Impact factor: 3.667

3.  Normalization of elevated cardiac, kidney, and hemolysis plasma markers within 48 h in Mexican Tarahumara runners following a 78 km race at moderate altitude.

Authors:  Dirk L Christensen; Diana Espino; Rocío Infante-Ramírez; Soren Brage; Dijana Terzic; Jens P Goetze; Jesper Kjaergaard
Journal:  Am J Hum Biol       Date:  2014-08-22       Impact factor: 1.937

4.  High-Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta-Analysis.

Authors:  Eslam Samaha; Audrey Avila; Mohammad A Helwani; Arbi Ben Abdallah; Allan S Jaffe; Mitchell G Scott; Peter Nagele
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

5.  Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon.

Authors:  Giuseppe Lippi; Federico Schena; Gian Luca Salvagno; Fabian Sanchis-Gomar; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 6.  Physical activity - an important preanalytical variable.

Authors:  Fabian Sanchis-Gomar; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.